Recently, Wang et al. demonstrated in a xenograft model of breast cancer that the administration of the anti-NG2/CSPG4 mAb225.28 diminished tumor growth, associated with reduced proliferation and vascular density, and increased apoptosis [13]. The gene discussed is CSPG4; the disease is breast cancer.